A Study of Tirzepatide (LY3298176) in Healthy Lactating Females

NCT05978713 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Tirzepatide

Sponsor

Eli Lilly and Company